KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novartis Ag (NVS) Accounts Payables (2016 - 2025)

Novartis Ag's Accounts Payables history spans 14 years, with the latest figure at $4.5 billion for Q4 2025.

  • On a quarterly basis, Accounts Payables fell 2.54% to $4.5 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $4.5 billion, a 2.54% decrease, with the full-year FY2025 number at $4.5 billion, down 2.54% from a year prior.
  • Accounts Payables hit $4.5 billion in Q4 2025 for Novartis Ag, down from $4.5 billion in the prior quarter.
  • Over the last five years, Accounts Payables for NVS hit a ceiling of $5.6 billion in Q4 2021 and a floor of $4.1 billion in Q2 2024.
  • Historically, Accounts Payables has averaged $4.8 billion across 5 years, with a median of $4.9 billion in 2021.
  • Biggest five-year swings in Accounts Payables: fell 22.5% in 2024 and later grew 8.68% in 2025.
  • Tracing NVS's Accounts Payables over 5 years: stood at $5.6 billion in 2021, then decreased by 7.33% to $5.1 billion in 2022, then fell by 4.28% to $4.9 billion in 2023, then dropped by 7.19% to $4.6 billion in 2024, then decreased by 2.54% to $4.5 billion in 2025.
  • Business Quant data shows Accounts Payables for NVS at $4.5 billion in Q4 2025, $4.5 billion in Q2 2025, and $4.6 billion in Q4 2024.